No abstract available
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Antimetabolites, Antineoplastic / therapeutic use
-
Azacitidine / therapeutic use*
-
Cohort Studies
-
Compassionate Use Trials / methods
-
Compassionate Use Trials / statistics & numerical data
-
Female
-
Follow-Up Studies
-
France
-
Humans
-
Male
-
Middle Aged
-
Myelodysplastic Syndromes / diagnosis
-
Myelodysplastic Syndromes / drug therapy*
-
Myelodysplastic Syndromes / etiology
-
Myelodysplastic Syndromes / mortality
-
Prognosis
-
Risk Factors
-
Survival Analysis
-
Time Factors
-
Treatment Outcome
Substances
-
Antimetabolites, Antineoplastic
-
Azacitidine